All Insights
Showing 1 - 12 of 8538
Life Sciences and Healthcare
EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026
First modules declared functional under phased approach, with vigilance and clinical studies still to follow
Financial regulation
The EU's SFDR 2.0 – what do asset managers need to know?
The European Commission has published its proposals for a significant overhaul of the EU’s sustainable finance disclosure framework
Business crime
UK Serious Fraud Office publishes guidance on how it will evaluate corporate compliance programmes
SFO sets expectations on compliance, cooperation and failure to prevent fraud
Competition, antitrust and trade
New EU economic‑security roadmap resets the bar for foreign investment into Europe
European Commission tightens foreign investment scrutiny, with plans to monitor portfolio investments for the first time
Life Sciences and Healthcare
Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal
Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector
Knowledge Notes
UK Knowledge Collection | DSA and GDPR compliance, Life Sciences and the Budget, and managing contractual breach
Welcome to this week's Knowledge Collection
IT and data
The implementation of the NIS-2 Directive in Germany – What are the deviations from the NIS-2 Directive?
Germany’s NIS-2 Act is in force now narrowing scope and adding a ‘critical’ tier compared to the NIS-2 Directive. With
Corporate
AIMing high, acting fast: the London Stock Exchange's feedback statement plans to revitalise AIM with immediate rule changes
LSE acts to introduce immediate flexibilities and a clear roadmap to a fuller rulebook consultation in the first half of
Commercial
Court of Appeal considers whether repudiatory breach capable of remedy under English law contract
Common law rules on repudiatory breach found not relevant to consideration of breach remedy provisions in contract
Group actions
The exclusive representative under the WAMCA
WAMCA – the exclusive representative This Insight is part of the series: Navigating Dutch Class Actions (WAMCA). Read our first
The Built Environment
How data centre developers and investors can approach strategic real estate considerations in Europe
Critical national infrastructure and essential entity statuses pose challenges beyond commercial property development
